BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Prognosis
9 results:

  • 1. Survival Outcomes of Patients with Mycosis Fungoides Involving the External Ear and Ear Canal.
    Wilkinson AJ; Nader ME; Roberts D; Duvic M; Gunther JR; Dabaja BS; Gidley PW
    Laryngoscope; 2023 Jun; 133(6):1486-1491. PubMed ID: 36054317
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. TRAF3 and NBR1 both influence the effect of the disease-causing cyld(Arg936X) mutation on NF-κB activity.
    Danis J; Kelemen E; Rajan N; Nagy N; Széll M; Ádám É
    Exp Dermatol; 2021 Nov; 30(11):1705-1710. PubMed ID: 33999445
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of putative phenotype-modifying genetic factors associated with phenotypic diversity in Brooke-Spiegler syndrome.
    Pap ÉM; Farkas K; Széll M; Németh G; Rajan N; Nagy N
    Exp Dermatol; 2020 Oct; 29(10):1017-1020. PubMed ID: 32744342
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating cyld Expression Mediated by Sponging miR-499-5p.
    Long J; Pi X
    Biomed Res Int; 2018; 2018():2086564. PubMed ID: 29808164
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited cyld defective skin tumours: study protocol for a randomised controlled trial.
    Cranston A; Stocken DD; Stamp E; Roblin D; Hamlin J; Langtry J; Plummer R; Ashworth A; Burn J; Rajan N
    Trials; 2017 Mar; 18(1):111. PubMed ID: 28270164
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Carcinoma of the external auditory canal: histological and treatment groups.
    Hosokawa S; Mizuta K; Takahashi G; Okamura J; Takizawa Y; Hosokawa K; Yamatodani T; Mineta H
    B-ENT; 2014; 10(4):259-64. PubMed ID: 25654948
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical significance of cyld downregulation in breast cancer.
    Hayashi M; Jono H; Shinriki S; Nakamura T; Guo J; Sueta A; Tomiguchi M; Fujiwara S; Yamamoto-Ibusuki M; Murakami K; Yamashita S; Yamamoto Y; Li JD; Iwase H; Ando Y
    Breast Cancer Res Treat; 2014 Feb; 143(3):447-57. PubMed ID: 24398777
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. cyld regulates keratinocyte differentiation and skin cancer progression in humans.
    Alameda JP; Fernández-Aceñero MJ; Moreno-Maldonado R; Navarro M; Quintana R; Page A; Ramírez A; Bravo A; Casanova ML
    Cell Death Dis; 2011 Sep; 2(9):e208. PubMed ID: 21900959
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. PHA skin test-correlation with migration inhibition but not with peripheral blood lymphocytes (PBL) subpopulations. With 1 figure.
    Szczylik C; Wiktor-Jedrzejczak W
    Allerg Immunol (Leipz); 1981; 27(3):162-7. PubMed ID: 6214937
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.